Observed Signal · Nov 5, 2026 · Funding · Source: Tech.eu (European Tech & Deals) · Impact: 1/5 · Sentiment: Positive
SFC Capital Backs Nayara's AI Patient Platform
UK-based healthcare AI company Nayara has raised a pre-seed funding round led by SFC Capital, an early-stage investor. The funding will support the development and expansion of Nayara's AI-powered platform designed to improve communication and support for patients between clinical appointments. Nayara develops AI companions for hospitals and healthcare systems, providing personalized guidance and proactive check-ins. The platform aims to reduce administrative workload for clinical teams by automating routine communication and flagging concerns. Already used in oncology for breast cancer patients, the funding will accelerate product development, clinical validation, and commercial expansion.
Funding news for a healthcare AI company, not directly related to AdTech/MarTech, but could have indirect implications for health-related advertising and patient engagement.
Track SFC Capital Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Nayara closed a pre-seed funding round led by SFC Capital.
- Nayara develops AI companions for hospitals and healthcare systems.
- The platform is already used in oncology for breast cancer patients.
- Funding will accelerate product development and clinical validation.
- Exact funding amount not disclosed.
Connected Companies & Entities
“SFC Capital is the early-stage investor that led the funding round.”
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Health Force Raises €4.2M for Hospital AI Agents
Barcelona-based Health Force, a HealthTech startup, raised €4.2 million in Seed funding to expand its enterprise-grade AI agents for hospital operations. The round was led by LUMO Labs with participation from Step Venture, Next Tier Ventures, Target Global, and Calm/Storm. Founded in 2022 in Vienna, Health Force automates administrative tasks in hospitals, such as prior-authorisation checks, claims processing, and regulatory reporting. The company reports that its AI agents handle 75% of cases autonomously and are deployed at leading Italian hospital groups, including Humanitas and Gruppo San Donato, processing over 200,000 patient cases annually. The company plans to use the funds to expand into new workflows and European markets including Germany, France, and Spain.
Orakl Oncology Raises €30M for AI Cancer Drug Prediction
Orakl Oncology, a French TechBio company, announced a €30 million ($34 million) Series A round co-led by Norrsken VC and Singular, with participation from InfraVia Capital Partners, Serena, Patient Autonome Fund managed by Bpifrance, Teampact Ventures, Plug and Play, and existing investors Verve Ventures VC, Speedinvest, and HCVC. The company uses AI and patient-derived tumor organoids to build 'virtual cancer patients' that predict drug performance in clinical trials, aiming to reduce the high failure rate in Phase 2 oncology trials. Orakl claims 90% accuracy in predicting clinical outcomes. The funding will expand its platform across more cancer types and geographies. Total funding now stands at €45 million.
Vera Health Raises $28.5M for Clinical AI Search
Vera Health, a clinical AI search engine for physicians, announced a $28.5 million Series A funding round led by Threshold Ventures, with participation from Optum Ventures, Mantis VC, and SV Angel. Existing investors Y Combinator and Gradient increased their backing, bringing Vera's total funding to $32 million. The platform, co-founded by Maxime Allouch and Taieb Bennani, helps clinicians find and evaluate medical evidence from over 60 million scientific publications, clinical guidelines, and drug labels. It is used by more than 800,000 clinicians across 190 countries. The company plans to use the funding to expand internationally, particularly in Europe, and to deepen integration with health systems and medical societies. Vera is free for clinicians and monetizes through institutional subscriptions and partnerships.
Receive all future signals for SFC Capital & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.